ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

NIH partners with biopharma to speed development of cancer immunotherapy work – Healthcare IT News

Healthcare IT NewsNIH partners with biopharma to speed development of cancer immunotherapy workHealthcare IT News“We have seen dramatic responses from immunotherapy, often eradicating cancer completely for some cancer patients,” NIH Director Francis … Continue reading

2017-10-13 Michael Zand NEWS

Brainstorm Health: Obamacare Insurer Payments, OptiNose IPO, Spark Gene Therapy – Fortune

Continue reading

2017-10-13 Michael Zand NEWS

Stand Up To Cancer Awards $5.5 Million for Epigenetic Immunotherapy Trials – AJMC.com Managed Markets Network

Stand Up To Cancer Awards $5.5 Million for Epigenetic Immunotherapy TrialsAJMC.com Managed Markets NetworkWhile many lung and bladder cancer patients respond well to immunotherapy, they eventually succumb to the disease because the immune system can no… Continue reading

2017-10-13 Michael Zand NEWS

No CRISPR for Sports – GenomeWeb

No CRISPR for SportsGenomeWebNew Scientist notes that the agency already prohibits the use of genetically modified cells and gene therapy and that the additional language appears to be aimed particularly at CRISPR-based gene editing. A WADA spokesperso… Continue reading

2017-10-13 Michael Zand NEWS

No CRISPR for Sports – GenomeWeb

No CRISPR for SportsGenomeWebNew Scientist notes that the agency already prohibits the use of genetically modified cells and gene therapy and that the additional language appears to be aimed particularly at CRISPR-based gene editing. A WADA spokesperso… Continue reading

2017-10-13 Michael Zand NEWS

Researchers learn more about toxic side effects of T-cell therapy pioneered at CHOP, Penn – Philly.com

Brainstorm Health: Obamacare Insurer Payments, OptiNose IPO, Spark Gene Therapy
Fortune
Happy Friday, Dailies. I thought I’d use this space today to highlight some great recent reporting by a couple of other dailies—you know, those things we used to call newspapers. Rolfe Winkler at the Wall Street Journal had a front-page eye-opener …

and more »

Continue reading

2017-10-13 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Signals Intraday Volatility – Down by 6.47% – First News 24

Editas Medicine, Inc. (NASDAQ:EDIT) Signals Intraday Volatility – Down by 6.47%First News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella … Continue reading

2017-10-13 Michael Zand NEWS

Advanced Gene-Editing Technology CRISPR-Gold Repairs DMD Mutation in Mice – Muscular Dystrophy News

Advanced Gene-Editing Technology CRISPR-Gold Repairs DMD Mutation in MiceMuscular Dystrophy NewsA new version of the CRISPR-Cas9 gene-editing technology called CRISPR-Gold has successfully restored the correct sequence of the dystrophin gene in a mouse… Continue reading

2017-10-13 Michael Zand NEWS
  • 1
  • …
  • 1,053
  • 1,054
  • 1,055
  • 1,056
  • 1,057
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Philly.com

Researchers learn more about toxic side effects of T–cell therapy pioneered at CHOP, Penn
Philly.com
The new cancer treatment, called CAR T-cell therapy, involves extracting immune cells called T cells from the patient, genetically modifying them to attack the cancer, and returning them to the patient’s body. One such treatment has been approved for …